AU5838794A - Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens - Google Patents

Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens

Info

Publication number
AU5838794A
AU5838794A AU58387/94A AU5838794A AU5838794A AU 5838794 A AU5838794 A AU 5838794A AU 58387/94 A AU58387/94 A AU 58387/94A AU 5838794 A AU5838794 A AU 5838794A AU 5838794 A AU5838794 A AU 5838794A
Authority
AU
Australia
Prior art keywords
particle
antigens
forming protein
hybrid
inducing segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58387/94A
Inventor
Sally Elizabeth Adams
Guy Timothy Layton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Bio Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939300818A external-priority patent/GB9300818D0/en
Priority claimed from GB939319573A external-priority patent/GB9319573D0/en
Application filed by British Bio Technology Ltd filed Critical British Bio Technology Ltd
Publication of AU5838794A publication Critical patent/AU5838794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU58387/94A 1993-01-16 1994-01-13 Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens Abandoned AU5838794A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB939300818A GB9300818D0 (en) 1993-01-16 1993-01-16 Proteinaceous particles
GB9300818 1993-01-16
GB9319573 1993-09-22
GB939319573A GB9319573D0 (en) 1993-09-22 1993-09-22 Proteinaceous particles
PCT/GB1994/000068 WO1994016084A1 (en) 1993-01-16 1994-01-13 Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens

Publications (1)

Publication Number Publication Date
AU5838794A true AU5838794A (en) 1994-08-15

Family

ID=26302301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58387/94A Abandoned AU5838794A (en) 1993-01-16 1994-01-13 Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens

Country Status (2)

Country Link
AU (1) AU5838794A (en)
WO (1) WO1994016084A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008005929A2 (en) * 2006-06-30 2008-01-10 New York University Recombinant hiv-1 gp120 immunogen with three different v3 loops from viruses of different clades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
DE3788806T2 (en) * 1986-11-01 1994-07-07 British Bio Technology SPHERICAL HYBRID HIV ANTIGENS.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides

Also Published As

Publication number Publication date
WO1994016084A1 (en) 1994-07-21

Similar Documents

Publication Publication Date Title
AU7593096A (en) Igg separation medium and novel protein a variant
AU7435296A (en) Novel expression vectors and methods of use
AU1019595A (en) Needle-suture assembly and packaging system
PL329930A1 (en) Antigens of human lymphocytes b and related reagents
AU5597094A (en) Ophtalmic surgical instrument and method
AU4896096A (en) Optically active aminoindane derivatives and preparation thereof
AU2325997A (en) Pillowed flexible cube-corner sheeting and methods of manufacture
AU1021997A (en) Cd100 antigen and uses therefor
AU2861695A (en) Mn gene and protein
AU2036495A (en) Crucifer AFT proteins and uses thereof
GB9516059D0 (en) Novel genes and proteins
AU3092995A (en) Breast specific genes and proteins
AU7607896A (en) Cathode-active material blends of lixmn2o4 and liy-alpha-mno2
AUPN631495A0 (en) Vaccine and biological vector(I)
AU1435695A (en) Recombinant human thymopoietin proteins and uses therefor
AU6862396A (en) Hybrid inflator and method of use
AUPN631395A0 (en) Vaccine and biological vector(II)
AU1367088A (en) Htlv-i peptide antigen and assay
AU7477094A (en) Hair penetrant and carrier
AU5838794A (en) Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens
AU5369396A (en) Rest protein and dna
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU3536895A (en) A new human peptide antibiotic (fall-39) and its use
IL116658A0 (en) Peptides their preparation and use
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof